Brand | ProteoGenix |
Product type | Peptides |
Applications | Advanced prostate cancer |
Brand: | ProteoGenix |
Product type: | Peptides |
Product reference: | PTX-OS-214766-78-6-47 |
Cas n°: | 214766-78-6 |
Product name: | Degarelix Peptide |
Notes: | WARNING: THIS PRODUCT IS INTENDED AS A RESEARCH PRODUCT ONLY. It is sold strictly for laboratory research purposes only but NOT for human use. They are not medicinal products and it can be harmful if ingested. Bodily introduction of any kind into humans or animals is strictly forbidden by law. |
Background information: | Degarelix is a selective antagonist of the hormone causing the release of Gonadotropins (GnRH). It attaches itself competitively and reversibly to receivers GnRH of the pituitary gland, thus rapidly causing a reduction in the release of Gonadotrophins, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and thus of the secretion of testosterone (T) by testicles. |
Size: | 1g |
Sequence : | Ac-D-2-Nal-D-Phe(4-Cl)-D-3-Pal-Ser-4-Aph(Hor)-D-4-Aph(Cbm)-Leu-Lys(ipr)-Pro-D-Ala-NH2 |
Purity: | 0.95 |
 form/format: | White powder |
Molecular formula: | C82H103ClN18O16 |
Molecular weight: | 1632.28 |
Storage conditions: | A cool(-20°C) & dry place protected from light, keep package close when not in use. |
Shipping condition: | Room temperature |
Research area: | Hormonal therapy |
Applications: | Advanced prostate cancer |
Applications of the peptide: | Advanced prostate cancer |
Alternatives names: | Degarelix acetate, FirMagon, N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-4-[2,6-dioxohexahydropyrimidin-4(S)-ylcarboxamido]-L-phenylalanyl-4-ureido-D-phenylalanyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide acetate, GNRHR |
Image: | |
Related products: | - ACTH (1-24), human Peptide - PT141 Acetate Peptide - Melanotan II Acetate Peptide |